3 ASX ETFs I'm buying in January 2026

As the calendar flips toward a new year, I'm not necessarily looking to overhaul my portfolio.

Instead, I'm focusing on a few new additions, including exchange traded funds (ETFs) that offer long-term tailwinds, diversification, and quality.

With that in mind, here are three top ASX ETFs I'm thinking of buying in 2026:

Betashares Global Cybersecurity ETF (ASX: HACK)

Cybersecurity has become a mission-critical necessity for businesses and consumers across the world. Governments, corporations, and consumers are all more dependent on digital infrastructure than ever, and the threat landscape continues to expand alongside it.

The Betashares Global Cybersecurity ETF provides exposure to companies operating at the front line of this arms race. Its holdings include global leaders such as Palo Alto Networks (NASDAQ: PANW), CrowdStrike Holdings (NASDAQ: CRWD), Fortinet (NASDAQ: FTNT), and Zscaler (NASDAQ: ZS). These businesses are deeply embedded in enterprise systems, with recurring revenue models and high switching costs.

Rather than betting on a single winner, this fund spreads risk across the sector, giving investors diversified exposure to a structural growth theme that looks set to persist well beyond 2026.

iShares S&P 500 ETF (ASX: IVV)

When it comes to core portfolio holdings, it is hard to look beyond exposure to the US market. The iShares S&P 500 ETF tracks 500 of America's largest listed companies. This offers instant diversification across industries, business models, and economic cycles.

While mega-cap technology stocks remain important components, the fund's exposure extends well beyond them. Non-tech holdings include Warren Buffett's Berkshire Hathaway (NYSE: BRK.B), UnitedHealth Group (NYSE: UNH), JPMorgan Chase (NYSE: JPM), Exxon Mobil (NYSE: XOM), and Procter & Gamble (NYSE: PG).

For investors who want reliable access to global innovation, strong earnings growth, and stocks with robust business models, the iShares S&P 500 ETF is a fund I would be happy to buy in 2026.

VanEck Morningstar Wide Moat ETF (ASX: MOAT)

The VanEck Morningstar Wide Moat ETF focuses on US stocks with sustainable competitive advantages and attractive valuations. This sort of focus is never a bad idea and has been championed by Warren Buffett for decades.

The ETF's portfolio includes stocks such as Thermo Fisher Scientific (NYSE: TMO), Merck & Co. (NYSE: MRK), Danaher (NYSE: DHR), Nike (NYSE: NKE), and Adobe (NASDAQ: ADBE).

For long-term investors who value resilience as much as growth, the VanEck Morningstar Wide Moat ETF offers a compelling blend of both. I would be happy to buy this again in January.

The post 3 ASX ETFs I'm buying in January 2026 appeared first on The Motley Fool Australia.

JPMorgan Chase is an advertising partner of Motley Fool Money. Motley Fool contributor James Mickleboro has positions in Nike and VanEck Morningstar Wide Moat ETF. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Adobe, Berkshire Hathaway, BetaShares Global Cybersecurity ETF, CrowdStrike, Danaher, Fortinet, JPMorgan Chase, Merck, Nike, Thermo Fisher Scientific, Zscaler, and iShares S&P 500 ETF. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Palo Alto Networks and UnitedHealth Group and has recommended the following options: long January 2028 $330 calls on Adobe and short January 2028 $340 calls on Adobe. The Motley Fool Australia has recommended Adobe, Berkshire Hathaway, CrowdStrike, Nike, VanEck Morningstar Wide Moat ETF, and iShares S&P 500 ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2025